Literature DB >> 22042467

Biliary complications after liver transplantation using grafts from donors after cardiac death: results from a matched control study in a single large volume center.

Michelle L DeOliveira1, Wayel Jassem, Roberto Valente, Shirin Elizabeth Khorsandi, Gregorio Santori, Andreas Prachalias, Parthi Srinivasan, Mohamed Rela, Nigel Heaton.   

Abstract

OBJECTIVE: To assess the incidence and impact of biliary complications in recipients transplanted from donors after cardiac death (DCD) at one single large institution.
BACKGROUND: Shortage of available cadaveric organs is a significant limiting factor in liver transplantation (LT). The use of DCD offers the potential to increase the organ pool. However, early results with DCD liver grafts were associated with a greater incidence of ischemic cholangiopathy (IC), leading to several programs to abandoning this source of organs.
METHODS: A retrospective analysis of a prospective database from April 2001 to 2010 focused on 167 consecutive DCD-LT. Each DCD transplant was matched with 2 brain death donors (DBD) grafts (n = 333) according to the period of transplantation. Primary outcome measures were biliary complications including the severity of complications, graft survival and patient survival. Minimum follow-up was 3 months.
RESULTS: Anastomotic stricture was the most common biliary complication (DCD = 30, 19% vs. DBD = 41, 13%). Most were treated endocoscopically (grade IIIa = 72%), whereas hepatico-jejunostomy (grade IIIb) was performed in 22%. Primary IC occurred in 4 (2.5%) recipients from the DCD group and was absent in the DBD group (P = 0.005). However, none of these patients required retransplantation. Patient and graft survival at 1, 3, and 5 years were similar between DCD and DBD groups (P = 0.106, P = 0.138, P = 0.113, respectively).
CONCLUSIONS: The encouraging results with DCD-LT are probably due to the selection of DCD grafts and clear definition of warm ischemia.

Entities:  

Mesh:

Year:  2011        PMID: 22042467     DOI: 10.1097/SLA.0b013e318235c572

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  23 in total

1.  Preliminary report of major surgery in liver transplant recipients receiving m-TOR inhibitors without therapeutic discontinuation.

Authors:  Lilian Schwarz; François Cauchy; Filomena Conti; Ailton Sepulveda; Fabiano Perdigao; Denis Bernard; Yvon Calmus; Olivier Soubrane; Olivier Scatton
Journal:  World J Surg       Date:  2014-12       Impact factor: 3.352

2.  Is liver transplantation using organs donated after cardiac death cost-effective or does it decrease waitlist death by increasing recipient death?

Authors:  Leigh Anne Dageforde; Irene D Feurer; C Wright Pinson; Derek E Moore
Journal:  HPB (Oxford)       Date:  2012-07-04       Impact factor: 3.647

3.  Can we reduce ischemic cholangiopathy rates in donation after cardiac death liver transplantation after 10 years of practice? Canadian single-centre experience

Authors:  Kerollos Wanis
Journal:  Can J Surg       Date:  2019-02-01       Impact factor: 2.089

Review 4.  Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation.

Authors:  Moustafa Mabrouk Mourad; Abdullah Algarni; Christos Liossis; Simon R Bramhall
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

5.  Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy.

Authors:  Thomas J Chirichella; C Michael Dunham; Michael A Zimmerman; Elise M Phelan; M Susan Mandell; Kendra D Conzen; Stephen E Kelley; Trevor L Nydam; Thomas E Bak; Igal Kam; Michael E Wachs
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

6.  Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation.

Authors:  Raffaele Cursio; Jean Gugenheim
Journal:  J Transplant       Date:  2012-02-29

7.  Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study.

Authors:  Christopher J Callaghan; Susan C Charman; Paolo Muiesan; James J Powell; Alexander E Gimson; Jan H P van der Meulen
Journal:  BMJ Open       Date:  2013-09-03       Impact factor: 2.692

Review 8.  Recent advances in understanding and managing liver transplantation.

Authors:  Francesco Paolo Russo; Alberto Ferrarese; Alberto Zanetto
Journal:  F1000Res       Date:  2016-12-21

9.  Liver transplantation for hepatocellular carcinoma using grafts from uncontrolled circulatory death donation.

Authors:  Anisa Nutu; Iago Justo; Alberto Marcacuzco; Óscar Caso; Alejandro Manrique; Jorge Calvo; Álvaro García-Sesma; María García-Conde; María Santos Gallego; Carlos Jiménez-Romero
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

10.  Protective Effects of Bone Marrow Mesenchymal Stem Cells (BMMSCS) Combined with Normothermic Machine Perfusion on Liver Grafts Donated After Circulatory Death via Reducing the Ferroptosis of Hepatocytes.

Authors:  Dong Sun; Liu Yang; Weiping Zheng; Huan Cao; Longlong Wu; Hongli Song
Journal:  Med Sci Monit       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.